1. MARKETS
  2. SECTOR : COMMERCIAL SERVICES & SUPPLIES
  3. INDUSTRY : MISCELLANEOUS COMMERCIAL SERVICES
  4. GRI BIO INC
GRI Bio Inc
XNAS: GRI
Download real time
2.18 0.00 (0.00%)
Near 52W Low of $2.10
24,663
XNAS Volume

XNAS 01 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for GRI Bio Inc

The latest disclosure was made by W. Marc Hertz in GRI Bio Inc where a trade of 103,067 Stock Option (Right to Buy) done was reported to US exchanges on Sept. 18, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
W. Marc Hertz Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2025 103,067 103,067 - - Stock Option (Right to Buy)
Vipin Kumar Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2025 43,222 43,222 - - Stock Option (Right to Buy)
David Baker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2025 23,605 23,605 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2025 23,605 23,605 - - Stock Option (Right to Buy)
Roelof Rongen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2025 23,605 23,605 - - Stock Option (Right to Buy)
David Szekeres Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2025 39,897 39,897 - - Stock Option (Right to Buy)
Leanne M. Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2025 43,222 43,222 - - Stock Option (Right to Buy)
W. Marc Hertz Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 26,688 26,688 - - Stock Option (Right to Buy)
Vipin Kumar Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 11,854 11,854 - - Stock Option (Right to Buy)
David Baker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 5,994 5,994 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 5,994 5,994 - - Stock Option (Right to Buy)
Roelof Rongen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 5,994 5,994 - - Stock Option (Right to Buy)
David Szekeres Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 10,276 10,276 - - Stock Option (Right to Buy)
Leanne M. Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 11,854 11,854 - - Stock Option (Right to Buy)
David Baker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2025 4,527 4,527 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2025 4,527 4,527 - - Stock Option (Right to Buy)
Roelof Rongen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2025 4,527 4,527 - - Stock Option (Right to Buy)
David Szekeres Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2025 7,545 7,545 - - Stock Option (Right to Buy)
W. Marc Hertz Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 129,730 129,730 - - Stock Option (Right to Buy)
Vipin Kumar Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 43,319 43,319 - - Stock Option (Right to Buy)
David Baker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 30,297 30,297 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 30,297 30,297 - - Stock Option (Right to Buy)
Roelof Rongen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 30,297 30,297 - - Stock Option (Right to Buy)
David Szekeres Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 51,937 51,937 - - Stock Option (Right to Buy)
Leanne M. Kelly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 43,319 43,319 - - Stock Option (Right to Buy)
David Szekeres Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 34,483 34,483 - - Stock Option (Right to Buy)
David Baker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 34,483 34,483 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 34,483 34,483 - - Stock Option (Right to Buy)
Roelof Rongen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 34,483 34,483 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters